AB Science S.A., a clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cancers in France. The company's lead drug candidate is masitinib, a selective protein kinase inhibitor that targets mast cells and microglia in Phase 3 trial for the treatment of amyotrophic lateral sclerosis, progressive forms of multiple sclerosis, Alzheimer's disease, and indolent...
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 33 1 47 20 00 14
Fax: 33 1 47 20 24 11
Address:
3, Avenue George V, Paris, France
